Skip to content

Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults

Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02675582
Enrollment
72
Registered
2016-02-05
Start date
2015-06-30
Completion date
2016-02-29
Last updated
2018-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Function and Mood

Brief summary

The primary objectives of this study are to assess the effects of three investigational drinks containing three botanicals in differing combinations versus a placebo control, on mood, psychological state, physical response, and cognitive performance during and after exposure to an observed multi-tasking stressor.

Interventions

Intervention involves consuming one beverage at the beginning of each visit during the incomplete block design sequence

Sponsors

Northumbria University
CollaboratorOTHER
PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 to 49 years * Self-report of good health * Are not excluded on the basis of the following

Design outcomes

Primary

MeasureTime frameDescription
Change in moodPre dose, 60, 150, 240 min post doseDuring each assessment mood and psychological state will be assessed before and after performance of an observed multi-tasking stressor via completion of the 'State' subscale of the State-Trait Anxiety Inventory and computerised versions of the Bond-Lader visual analogue mood scales and separate visual analogue scales (VAS) measuring subjective stress, relaxation and calmness.

Secondary

MeasureTime frameDescription
Change in Cognitive functionPre dose, 60, 150, 240 min post doseDuring each assessment mood and psychological state will be assessed before and after performance of an observed multi-tasking stressor via completion of the 'State' subscale of the State-Trait Anxiety Inventory and computerised versions of the Bond-Lader visual analogue mood scales and separate visual analogue scales (VAS) measuring subjective stress, relaxation and calmness.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026